Viewing Study NCT02550535


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2026-02-02 @ 6:10 PM
Study NCT ID: NCT02550535
Status: COMPLETED
Last Update Posted: 2018-10-02
First Post: 2015-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients
Sponsor: Cell Medica Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes (MDS) View
None Acute Myeloid Leukaemia (AML) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None WT1 TCR View
None Gene modified T cels View
None Gene Therapy View